DESIGN, DEVELOPMENT AND CHARACTERIZATION OF EXTENDED RELEASE MULTIUNIT PARTICULATE SYSTEM OF ANTI-INFLAMMATORY DRUG
Abstract
Multi unit particulate system has long been employed to improve the bioavailability of drugs. Mesalamine pellets were prepared by Coating drug solution on sugar sphere followed by various functional coating. The influence of rate controlling membrane made up of Eudragit RSPO and Eudragit RLPO in combination with delay release polymer coating with Eudragit L100 in different proportions on drug release kinetics was studied. Pellets were for the various parameter like Physical characteristics, assay and in-vitro dissolution profile. The study confirmed that mesalamine can be delivered by multi unit particulate system into lower part of intestine. Optimized formulations were evaluated for In-vitro release profile. The optimized formula was stable at accelerated storage condition 40°C / 75 % RH. Prepared Pellets can be used in the treatment of the ulcerative colitis.
Keywords:
Mesalamine, Eudragit RSPO and Eudragit RLPO, Eudragit L100, in vitro release.DOI
https://doi.org/10.25004/IJPSDR.2009.010209References
Ghebre-Sellassie, Marcel Dekker, Pharmaceutical Pelletization Technology, New York, 1989.
Jalal IM, Malinowski HJ, Smith WE. Tablet granulations composed of spherical-shaped particles. J Pharm Sci 1972; 61:1466-790.
Malinowski HJ, Smith WE. Effect of spheronization process variables on selected tablet properties. J Pharm Sci 1974; 63: 285-288.
Nakahara, US Patent 3, 277, 520. October 1966.
Herbert A. Liberman and Leon Lachman: The Theory and Practice of Industrial Pharmacy”, IIIrd Edition. Verghese Publication House, 171, 293.
ICH topic 8 Pharmaceutical guidelines: Note for Guidance on Pharmaceutical Developments, (EMEA/CHMP167068/2004)
ICH Q1A (R2), Stability Testing Guidelines: Stability testing of a new drug product and new drug substance.
Published
Abstract Display: 167 
PDF Downloads: 281 
